SuperGen to Present at 7th Annual BIO Investor Forum on October 29, 2008

Thursday, October 23, 2008 General News J E 4
DUBLIN, Calif., Oct. 22 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery anddevelopment of novel cancer therapies, today announced that James S. Manuso,Ph.D., President and Chief Executive Officer, is scheduled to present at the7th Annual Biotechnology Industry Organization (BIO) Investor Forum onWednesday, October 29, 2008, at the Palace Hotel in San Francisco.

SuperGen's presentation at the BIO Investor Forum is scheduled to begin at4:15 p.m. PDT (7:15 p.m. EDT). A live webcast of the presentation will beavailable on the investor relations section of the Company's Web site A webcast replay of the presentation will be availableshortly following the live event.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development Tel: (925) 560-0100 Email: Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail:

SOURCE SuperGen, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
VeraTag(TM) Assays Featured at EORTC-NCI-AACR Symp...
Mylan Receives Tentative FDA Approval for First-to...